Table 2.
Network name | FDR | Associated human gene |
---|---|---|
Development: Cartilage development | BMP4, BMP6, COL12A1, SOX9, CTGF | |
Cell adhesion: Cell-matrix interactions | COL12A1, THBS1, MMP9, VCAN, ITGA11, TNC, COL10A1 | |
Immune response: Th17-derived cytokines | CXCL12, IL17RC, MMP9, JUN | |
Development: Ossification and bone remodeling | BMP4, BMP6, OSTN, FOXO1, COL10A1, POSTN | |
Signal Transduction: BMP and GDF signaling | BMP4, BMP6, CDKN1B, GADD45B, SOX9 | |
Development: EMT: Regulation of epithelial-to-mesenchymal transition | BMP4, HMGA2, MMP9, JUN, CDKN1B, SOX9, CTGF | |
Proteolysis: ECM remodeling | MMP9, TNC, COL10A1, CTGF | |
Signal Transduction: ESR1-nuclear pathway | CYP1A1, CXCL12, BMP6, ADM, JUN, FOXO1, CYP1B1 | |
Reproduction: FSH-beta signaling pathway | BMP4, JUN, FOXO1, CDKN1B, CTGF | |
Development: Blood vessel morphogenesis | EPAS1, CXCL12, BMP4, FOXO1, CTGF, ANGPT4 |
Note: The Bioconductor package edgeR (statistical methodology based on the negative binomial distribution) was used to calculate the significant differentially expressed genes (, BH-adjusted ), in comparison with the vehicle control (0.1% DMSO). The human orthologs of the gene list were then submitted to MetaCore to identify significantly enriched process networks using a hypergeometric distribution, where the p-value is the probability that a gene set maps to a manually curated GeneGo Process Network or is overrepresented in comparison with the background gene list. Enriched process networks were considered significant with an . ; ; ; ; ; ; ; ; ; ; ; .